Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads.
The Orbit peptide display engine is uniquely able to address cell-based targets and thereby screen targets in relevant contexts.
Peptide leads are key starting points for the development of peptide, peptidomimetic and small molecule therapeutics as well as bioconjugates for cell targeting and cargo delivery.
Founded in late 2015 as a spin-out from Oxford University based on the work of Professors Graham Ogg and Terry Rabbitts. We have a pipeline of novel targets in in-house programmes and we work in collaboration with others in industry and academia to make our technology as accessible as possible.
Location: United Kingdom, England, Oxford
Employees: 11-50
Total raised: $16.82M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| - | Oxford Inv... | oxfordinve... |
| - | Perivoli I... | perivoliin... |
| - | Oxford Sci... | oxfordscie... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.07.2021 | - | $7.6M | - |
| 23.05.2018 | Series A | $9.22M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 07.03.2022 | Orbit Discovery and WuXi AppTec sign agreement to access pep... | Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technolo... | cambridgen... |
| 21.07.2021 | Orbit Discovery Raises $7.6M in Funding | Orbit Discovery, an Oxford, England, UK-based biopharmaceutical company focused on discovering candi... | finsmes.co... |
| 20.07.2021 | Orbit Discovery announces $7.6 million funding to accelerate... | Orbit Discovery announces $7.6 million funding to accelerate growth in peptide discovery business 2... | cambridgen... |
| 20.07.2021 | Orbit Discovery announces $7.6 million funding to accelerate... | Oxford...Orbit Discovery Ltd, a privately held biopharmaceutical company focused on discovering cand... | cambridgen... |
| 20.07.2021 | Orbit Discovery : Announces $7.6 Million Funding to Accelera... | Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering c... | marketscre... |
| 29.06.2021 | Orbit Discovery appoints Dr Neil Butt as Chief Executive Off... | Orbit Discovery appoints Dr Neil Butt as Chief Executive Officer 29-06-2021 Oxford, UK, June 29, 2... | cambridgen... |
| 23.05.2018 | Peptide Display Company Orbit Discovery Raises £6.9M in Seri... | Orbit Discovery Ltd, an Oxford, UK-based biotech company developing a peptide identification and opt... | finsmes.co... |
| 23.05.2018 | Term Sheet — Wednesday, May 23 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content You can't secure what you can... | fortune.co... |